Benjamin R. Yerxa

Double-Masked, Placebo-Controlled Safety and Efficacy Trial of Diquafosol Tetrasodium (INS365) Ophthalmic Solution for the Treatment of Dry Eye

Joseph Tauber, William F. Davitt, John E. Bokosky et al. · Cornea · 2004 · 168 citations

Medicine, Ophthalmology, Pharmacology +17

Rabbit conjunctival epithelium transports fluid, and P2Y2₂receptor agonists stimulate Cl⁻and fluid secretion

Yansui Li, Kunyan Kuang, Benjamin R. Yerxa et al. · American Journal of Physiology-Cell Physiology · 2001 · 158 citations

Life Sciences, Cell Biology, Pharmacology +14

Pharmacology of INS37217 [P1-(Uridine 5′)-P4- (2′-deoxycytidine 5′)tetraphosphate, Tetrasodium Salt], a Next-Generation P2Y2 Receptor Agonist for the Treatment of Cystic Fibrosis

Benjamin R. Yerxa, Juan Sabater, C. William Davis et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 150 citations

Medicine, Molecular Biology, Pharmacology +15

Synthesis and P2Y receptor activity of a series of uridine dinucleoside 5′-polyphosphates

William Pendergast, Benjamin R. Yerxa, James G. Douglass et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 122 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +8

Localization of ocular P2Y2 receptor gene expression by in situ hybridization

Matthew S. Cowlen, Vivian Z. Zhang, Lisa Warnock et al. · Experimental Eye Research · 2003 · 119 citations

Life Sciences, Genetics, Molecular Genetics +5